Scleroderma

Scleroderma also known as systemic sclerosis, is a systemic autoimmune disease characterized by damage to endothelial and smooth muscle cells of the small arteries. Replacement with fibrous material results, and there is an influx of inflammatory cells. Primarily affects skin and joints but can affect the heart and lungs, and digestive tract. Some types of scleroderma are rapidly progressive and deadly. Scleroderma is often treated with immunosuppressive drugs, and there is no known cure. Some investigators are looking at using the regenerative properties of cell therapy to mitigate the impact of scleroderma. Research is ongoing to evaluate the effects of stem cells on auto-immune conditions. As recently stated in Best Practices & Research Clinical Rheumatology in a review of Scleroderma, “Stem cell transplantation seems to be promising in restarting the immune system to diminish fibrosis and restore microvasculature.” Read More…

Scleroderma and Chicago Stem Cell Treatment Center

CHICAGO STEM CELL TREATMENT CENTER AND CELL SURGICAL NETWORK has developed a specific SVF deployment protocol that attempts to utilize the immuno-regulatory and anti-inflammatory properties of SVF (rich in mesenchymal stem cells and growth factors) to mitigate the effects of scleroderma. SVF is deployed systemically and may require repeat dosing. This is done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately three hours.

Schedule your Consultation with Dr. Ritacca Today

Do you have additional questions on how stem cells work and how they relate to your condition?  Contact us today to schedule your no-obligation consultation with Dr. Ritacca, Founder of the Chicago Stem Cell Treatment Center.  To get the process started, simply fill out our short CSCTC Confidential Candidate Application.  Once we receive your application, a stem cell coordinator will call you to schedule your phone or in person consultation with Dr. Ritacca. We look forward to educating you on the latest research for stem cell therapy.